Cell & Gene: The Podcast
Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.
Podcasting since 2021 • 86 episodes
Cell & Gene: The Podcast
Latest Episodes
A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses ...
•
Episode 85
•
28:06
Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts
Allogene Therapeutics' EVP of R&D and CMO, Dr. Zachary Roberts, penned an original article for Cell & Gene titled, The Path Forward for CLL is Allogeneic. In his article, Dr. Roberts explains that chronic lymphocytic leukemia (CLL) is t...
•
Episode 84
•
25:13
CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.
Applications (BLAs) of recent approvals and complete responses for novel products or rare diseases as well as BLAs currently under review. Benton shares information about FDA Draft Gudiances, including Platform Technology Designation Program fo...
•
Episode 83
•
27:58
Identifying Drug Development Opportunities for DMD with CureDuchenne
Debra Miller, CEO and Founder and Dr. Michael Kelly, Chief Scientific Officer at CureDuchenne talk to Host Erin Harris about the FDA approval for the expansion to the label indication for ELEVIDYS from Sarepta Therapeutics as well as how CureDu...
•
Episode 82
•
29:55
Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington
Lucas Harrington, Co-Founder and Chief Scientific Officer of Mammoth Biosciences, joins Erin Harris to shed light on the biotech's proprietary ultracompact CRISPR systems to develop potential long-term curative therapies for patients with life-...
•
Episode 81
•
21:01
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
